Overview

KRN7000 in Chronic Hepatitis B

Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to determine the safety, tolerability and effectiveness of KRN7000 for chronic hepatitis B infection.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Foundation for Liver Research
Treatments:
KRN 7000